The Glycaemic Effect of Isomaltulose Consumption in Healthy Participants

NCT ID: NCT03020485

Last Updated: 2017-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-12-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to determine the glycaemic effect of isomaltulose and sucrose in Chinese, Indian, Malay, and Caucasian individuals. The current study will provide important information on the potential health benefits of isomaltulose consumption in Asian population. It will also reveal how the three main ethnicities in Singapore respond to isomaltulose and whether the response differs from the Caucasians.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of the present study is to investigate the glycaemic effect of isomaltulose in Chinese, Indians, Malays and Caucasians. This will be a single intervention. Up to fifty participants, consisting of at least ten Chinese, ten Malays, ten Indians, and ten Caucasians completed data sets, aged between 21 and 40 years will be recruited from the general public in Singapore. Participants will be asked to attend two test sessions for this study. Participants will consume either a sucrose drink or an isomaltulose drink (each containing 50 g of available carbohydrate).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Isomaltulose

50g of isomaltulose dissolved in 250ml of water

Group Type EXPERIMENTAL

Isomaltulose

Intervention Type OTHER

Isomaltulose is a disaccharide made up of one molecule glucose and fructose with a (α1-6) linkage.

Sucrose

50g of sucrose dissolved in 250ml of water

Group Type EXPERIMENTAL

Sucrose

Intervention Type OTHER

Sucrose is normal table sugar

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Isomaltulose

Isomaltulose is a disaccharide made up of one molecule glucose and fructose with a (α1-6) linkage.

Intervention Type OTHER

Sucrose

Sucrose is normal table sugar

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chinese, Indian, Malay or Caucasian ethnic origin

Exclusion Criteria

* People with major chronic disease such as heart disease, cancer or diabetes mellitus
* Individuals with food intolerances or allergies to isomaltulose or sucrose
* Individuals who are taking insulin or drugs known to affect glucose metabolism and body fat distribution
* People with a major medical or surgical event requiring hospitalization within the preceding 3 months
* Individuals with the presence of disease or drugs which influence digestion and absorption of nutrients
* Pregnant women
Minimum Eligible Age

21 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Singapore Institute of Food and Biotechnology Innovation

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Melvin Leow

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Melvin Leow, MD

Role: PRINCIPAL_INVESTIGATOR

Clinical Nutrition Research Centre

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014/01008

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Sucrose on Liver Fat
NCT02015442 COMPLETED NA